Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Utah Medical Products/Vital Signs Inc.

This article was originally published in The Gray Sheet

Executive Summary

Utah Medical Products/Vital Signs Inc.: Firms enter agreement under which Vital Signs will market Utah Medical's Deltran IV disposable blood pressure transducer (DPT) in the U.S. Manufactured via an automated process, the Deltran IV is a lower cost version of Utah Medical's hand-assembled Deltran II DPT, which is marketed in the U.S. by Baxter under the name Uniflow. The agreement follows Utah Medical's March announcement that it would seek new marketing partners for the Deltran line due to Baxter's decision to cut back its distribution of the Deltran II and to phase out distribution of Utah Medical's Summit DPT ("The Gray Sheet" March 11, I&W-7). The company notes that it may be nearing another marketing agreement for Deltran IV with a "significant medical monitoring equipment company in the U.S."...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006247

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel